Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression (OMIMYDep)- A Double-blind Randomized Controlled Trial

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder. Outcome measures including clinical symptoms, inflammation biomarkers and gut microbiota profiles.

Inclusion Criteria:

• Youth with a DSM-5 diagnosis of MDE

Exclusion Criteria:

• Has a recent change in antidepressants or psychotherapy treatment within 4 weeks.
• Allergic to omega-3 fatty acids